Pfizer vaccine less effective against key S.African mutations - study
Published
Published
The latest study, which has not yet been peer reviewed, was conducted on 10 mutations, which are characteristic of the variant..
Pfizer Inc and BioNTech's COVID-19 vaccine appeared to work against a key mutation in the highly transmissible new variants of the..